Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Pediatr Transplant. 2012 Mar;16(2):106-22. doi: 10.1111/j.1399-3046.2012.01644.x.

Current status of immunosuppressive agents for solid organ transplantation in children.

Author information

  • 1Paediatric Liver GI and Nutrition Centre, King's College Hospital, King's College London School of Medicine, London, UK.


Immunosuppression after organ transplantation is complex and ever evolving. Over the past two decades, newer immunosuppressive agents have been introduced with an aim to provide better patient and graft survival. Improved therapeutic strategies have been developed offering the option to use combinations of drugs with non-overlapping toxicities. There are, however, only a few clinical studies with robust data to rationalize the use of these agents in children. This review will discuss the newer immunosuppressive agents used for solid organ transplant, their current status in post-transplant management and prevention of allograft rejection.

© 2012 John Wiley & Sons A/S.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk